Difference between revisions of "Team:NRP-UEA-Norwich/Collaborations/Manchester"

 
(20 intermediate revisions by 2 users not shown)
Line 104: Line 104:
 
     <div class="col-md-6 left">
 
     <div class="col-md-6 left">
 
     <h1 class="title1">Manchester-Graz Collaboration</h1>
 
     <h1 class="title1">Manchester-Graz Collaboration</h1>
                                         <p class="space20"> The Manchester-Graz team have developed an expression system designed to regulate single and multi-gene pathways for an intestine expression. For controlling a wide range of pathways it is designed in a flexible and modular manner. They tested the production of butyrate in the gut. The pathway was incorporated into the expression system model to observe the expression of butyrate under the control of the developed system. The model generated helped us to understand how the system is dealing with pathways that consist of several enzymes at an intestine level.  </p>
+
                                         <p class="space20"> The Manchester-Graz team have developed an expression system designed to regulate single and multi-gene pathways for an intestine expression. For controlling a wide range of pathways it is designed in a flexible and modular manner. They tested the production of butyrate in the gut. The pathway was incorporated into the expression system model to observe the expression of butyrate under the control of the developed system. The model generated helped us to understand how the system is dealing with pathways that consist of several enzymes at an intestinal level.  </p>
  
<p class="space20">The system consists of two quorum sensing (QS) systems EsaR/I and CepR/I. The EsaR/I system belongs to the plant pathogen Pantoea stewartii. The second QS-System, CepR/I, belongs to the opportunistic pathogen Burkholderia cenocepacia.  For details about the system and the model please look into: https://2015.igem.org/Team:Manchester-Graz/modelling.</p>
+
<p class="space20">The system consists of two quorum sensing (QS) systems <i>Esa</i>R/I and <i>Cep</i>R/I. The <i>Esa</i>R/I system belongs to the plant pathogen <i> Pantoea stewartii </i>. The second QS-System, CepR/I, belongs to the opportunistic pathogen <i> Burkholderia cenocepacia </i>.  For details about the system and the model please look into <a href="https://2015.igem.org/Team:Manchester-Graz/Modeling" style = "color: #002bb8;">the Manchester-Graz modelling page</a>.</p>
  
    <p class="space10">Butyrate is converted starting from two Acetyl CoAs over several steps to Butyryl CoA. In the last step the Coenzyme A is transferred to Acetate, producing Acetyl CoA and Butyrate (1).
 
For simplicity, the pathway was reduced to some essential parts and steps in the pathway. Acetate is converted to Acetyl CoA. The steps to Butyryl CoA are reduced to one step. Coenzyme A is recycled in the last step to Butyrate and can be reused to produce Acetyl CoA (Fig 1). </p>
 
  
 
     </div>
 
     </div>
Line 116: Line 114:
  
 
                             <img src="https://static.igem.org/mediawiki/2015/e/e2/NRP-UEA-Norwich-grazmodel1.png" href="https://static.igem.org/mediawiki/2015/e/e2/NRP-UEA-Norwich-grazmodel1.png" alt="..." class="img-responsive mautomargin fancybox" style="cursor: pointer;">
 
                             <img src="https://static.igem.org/mediawiki/2015/e/e2/NRP-UEA-Norwich-grazmodel1.png" href="https://static.igem.org/mediawiki/2015/e/e2/NRP-UEA-Norwich-grazmodel1.png" alt="..." class="img-responsive mautomargin fancybox" style="cursor: pointer;">
<p><b>Figure 1:</b> Overview of the reduced pathway. Coenzyme A (Co A) is recycled in the pathway by the butyryl CoA-acetyl CoA-tranferase.
+
<p><b>Figure 1:</b> Overview of the reduced pathway. Coenzyme A (CoA) is recycled in the pathway by the butyryl CoA-acetyl CoA-tranferase.
 
</p>
 
</p>
 
                          
 
                          
Line 134: Line 132:
 
     <div class="row">
 
     <div class="row">
 
     <div class="col-md-12 left">
 
     <div class="col-md-12 left">
 
+
    <p class="space10">Butyrate is converted starting from two acetyl-CoAs over several steps to butyryl-CoA. In the last step, the coenzyme A is transferred to acetate, producing acetyl-CoA and butyrate<sub><a data-id="ref" class="scroll-link" style = "color: #002bb8;">1</a></sub>.
<h2 class="title1">Acylation simulation </h2>
+
For simplicity, the pathway was reduced to some essential parts and steps in the pathway. Acetate is converted to acetyl-CoA. The steps to butyryl-CoA are reduced to one step. Coenzyme A is recycled in the last step to butyrate and can be reused to produce acetyl-CoA (Figure 1). </p>
<p class="space20">
+
Bacterial glycogen and plant starch consist of chains of glucose residues connected by alpha-1,4-glycosidic linkages with alpha-1,6-glycosidic linkages forming branch points. Our  main aim was to produce acylated or butrylated starch. As plants are more difficult to work with, we initially expressed four putative acyltransferases in <i>E. coli </i>to see if we could modify bacterial glycogen. However, the activity on these enzymes is still unknown. We don't know at which position in the glucose molecule that the enzyme might add the acyl group. If the group is added to the free end available at a growing branch, it will compete with the glycogen synthase and disrupt the growth of the molecule. </p>
+
 
<div class="space10"></div>
 
<div class="space10"></div>
<p>Even though glycogen acylation has not yet been described, phosphorylation of glycogen has been studied previously in both muscle and bacterial glycogen. Tagliabracci V. S. et al showed that the phosphate in glycogen is present as C2 and C3 phosphomonoesters <sub><a data-id="ref" class="scroll-link" style = "color: #002bb8;">3</a></sub> . Phosphorylation of starch has been also characterized2. According to Blennow A. et al, the phosphate groups bind at the free C6 and C3 hydroxyl groups of the glucose units. Both groups are located at the hydrophilic surface of the double helix, which might affect the stability of the molecule <sub><a data-id="ref" class="scroll-link" style = "color: #002bb8;">4</a></sub>.
 
</p>
 
  
<p class="space20">
+
<p class="space20"></p>
We therefore needed to model the putative changes in glycogen structure depending on the location of the modification. Our aim was to produce carbohydrate molecules with 5-10% of the residues modified since this level of butrylation (achieved by chemical modification) has positive benefits to the colon of rats <sub><a data-id="ref" class="scroll-link" style = "color: #002bb8;">5</a></sub>  Our model indicates that this level of modification is only viable if the enzyme can modify any base -  If it can only use the carbon-4 position it would impact on the growth of the molecule.
+
</p>
+
 
</div>
 
</div>
  
 
<div class="col-md-6 left">
 
<div class="col-md-6 left">
<h3 class="title2">Glyco2D Works!</h3>
 
  
     <p class="space20">When we increase the initial percentage of random acylation, the total number of modified glucoses increased. We showed a great linear correlation between both (see figure 3) </p>
+
     <p class="space20">The pathway is controlled by three enzymes whose expression is controlled by the two quorum sensing systems.
 +
</p>
  
 +
<p class ="space20">If we simulate the model, in the first two minutes the acetate gets first converted into butyryl-CoA and then the butyrate production starts (see Figure 2). The following time is butyrate being produced constantly by the cells. The butyrate is transported out of the cells through diffusion by a rate of 207.6 µmol/h/L or 18 mg/h/L.</p>
  
    </div>
+
<img src="https://static.igem.org/mediawiki/2015/8/83/NRP-UEA-Norwich-manchester3.png" href="https://static.igem.org/mediawiki/2015/8/83/NRP-UEA-Norwich-manchester3.png" alt="..." class="img-responsive mautomargin fancybox space10" style="cursor: pointer;">
    <div class="col-md-5 col-md-offset-1  col-sm-offset-1  space30">
+
<p><b>Figure 2:</b> Butyrate production in the first two minutes.</p>
                    <div class="success-work project">
+
                       
+
                          <img src="https://static.igem.org/mediawiki/2015/e/e4/NRP-UEA-Norwich-acylation-fig1.png" href="https://static.igem.org/mediawiki/2015/e/e4/NRP-UEA-Norwich-acylation-fig1.png" alt="..." class="img-responsive mautomargin fancybox" style="cursor: pointer;">
+
                        <p><b>Figure 3:</b> A graph showing the results from Glyco2D acylation simulation.</p>
+
                       
+
                    </div>
+
 
+
</div>
+
<div class="space30"></div>
+
<div class="col-md-6 left">
+
<h3 class="title2">Acylation on carbon 4</h3>
+
 
+
    <p class="space20">As we're using putative acyltransferases, we don't know the carbon in the glucose molecule that gets acylated. If it binds to C4, the acylation will restrict further growth of the glycogen molecule. </p>
+
 
+
        <p class="space20">As we can see, by having a chance of acylation of 1% at C4, the glucose lost is around 50%. By 'glucose lost' we mean all the glucose molecules that could haven been added to the unmodified molecule (see figure 4). </p>
+
 
+
        <p class="space20">Therefore, if the acyl group always binds to C4, we won't have a viable glycogen molecule (see figure 5). </p>
+
 
+
<img src="https://static.igem.org/mediawiki/2015/8/8b/NRP-UEA-Norwich-acylation-fig2.png" href="https://static.igem.org/mediawiki/2015/8/8b/NRP-UEA-Norwich-acylation-fig2.png" alt="..." class="img-responsive mautomargin fancybox" style="cursor: pointer;">
+
<p><b>Figure 4:</b> Results from acylation simulation with acyl group added into carbon 4.</p>
+
  
  
Line 180: Line 153:
 
     <div class="col-md-5 col-md-offset-1  col-sm-offset-1  space30">
 
     <div class="col-md-5 col-md-offset-1  col-sm-offset-1  space30">
 
                     <div class="success-work project">
 
                     <div class="success-work project">
                          <img src="https://static.igem.org/mediawiki/2015/8/8e/NRP-UEA-Norwich-modelling-modified-structure.png" href="https://static.igem.org/mediawiki/2015/8/8e/NRP-UEA-Norwich-modelling-modified-structure.png" alt="..." class="img-responsive mautomargin fancybox" style="cursor: pointer;">
 
<p><b>Figure 5:</b> A modified glycogen structure where acylation will restrict growth produced by Glyco2D. Glucose molecules with acyl groups added are coloured in red.</p>
 
 
                          
 
                          
 +
                          <img src="https://static.igem.org/mediawiki/2015/2/29/NRP-UEA-Norwich-pathwaything.png" href="https://static.igem.org/mediawiki/2015/2/29/NRP-UEA-Norwich-pathwaything.png" alt="..." class="img-responsive mautomargin fancybox" style="cursor: pointer;">
 +
                        <p><b>Figure 3:</b> Overview of the Simbiology model. For simplification the model was reduced to essential components.</p>
 
                          
 
                          
 
                     </div>
 
                     </div>
  
</div>   
 
 
</div>
 
</div>
<div class="col-md-6 left">
 
<h3 class="title2">Acylation in any available position</h3>
 
    <p class="space20">Another hypothesis is that the acyltransferase can add the group to any carbon on the glucose molecule. We assume a random chance of a group being added on the 4 carbons available in the molecule. If it is added to C4, it will restrict growth. If it is added to C6, it might restrict branching if it binds to the glucose molecule in the 5th or 10th position in the chain (branching points). The normal growth will not be altered if it binds C2 or C3.</p>
 
 
        <p class="space20">We ran the simulation 300 times for each % of acylation and calculated the average for all the possible randomly generated molecules. We observed a good correlation between the final % of acylated glucose residues and the % of glucose molecules that are lost in comparison to the unmodified molecule (see figure 6).
 
</p>
 
<p class="space20">As we can see, when a 5% of final acylation is achieved, only a 22 % of the glucose in the molecule is lost, and this give rise to a valid glycogen molecule. This model allowed us to define the optimal value so that the minimum amount of glucose units are lost from the glycogen molecule but we achieve the desired level of acylation. </p>
 
 
<img src="https://static.igem.org/mediawiki/2015/0/0b/NRP-UEA-Norwich-acylation-fig3.png" href="https://static.igem.org/mediawiki/2015/0/0b/NRP-UEA-Norwich-acylation-fig3.png" alt="..." class="img-responsive mautomargin fancybox" style="cursor: pointer;">
 
<p><b>Figure 6:</b> Acylation simulation results: total glucose lost for different percentages of overall acylation percentage.</p>
 
 
 
    </div>
 
    <div class="col-md-5 col-md-offset-1  col-sm-offset-1  space30">
 
                    <div class="success-work project">
 
                          <img src="https://static.igem.org/mediawiki/2015/5/59/NRP-UEA-Norwich-modelling-random-structure.png" href="https://static.igem.org/mediawiki/2015/5/59/NRP-UEA-Norwich-modelling-random-structure.png" alt="..." class="img-responsive mautomargin fancybox" style="cursor: pointer;">
 
<p><b>Figure 7:</b> A modified glycogen structure where acylation may restrict growth depending on where the acyl groups are added. Glucose molecules with acyl groups added are coloured in red.</p>
 
                       
 
                       
 
                    </div>
 
  
</div> 
 
  
 
<div class="col-md-12 left">
 
<div class="col-md-12 left">
Line 219: Line 170:
 
                     <div class="success-work science">
 
                     <div class="success-work science">
 
        
 
        
                         <img src="https://static.igem.org/mediawiki/2015/thumb/1/19/NRP-UEA-Norwich-Pathwaytthing.png/800px-NRP-UEA-Norwich-Pathwaytthing.png">
+
                         <img src="https://static.igem.org/mediawiki/2015/2/29/NRP-UEA-Norwich-pathwaything.png">
 
                      
 
                      
 
                     </div>-->
 
                     </div>-->
Line 228: Line 179:
 
    
 
    
 
</section>
 
</section>
 +
  
 
     </div>
 
     </div>
 +
<div class="space30" id="ref"></div>
 +
    <div class="col-md-12 left">
 +
    <h2 class="title1" id="ref">References</h2>
 +
 +
<p >1. Susan E et al (2002) The microbiology of butyrate formation in the human colon.</p>
 +
<div class="space30"></div>
 +
</div>
  
 
<div class="space30"><span></div>
 
<div class="space30"><span></div>
Line 249: Line 208:
 
     <li><img src="https://static.igem.org/mediawiki/2015/9/9c/NRP-UEA-Norwich-Ibcarb_logo.png" width="200" height="100" class="img-grey mautomargin"></a></li>
 
     <li><img src="https://static.igem.org/mediawiki/2015/9/9c/NRP-UEA-Norwich-Ibcarb_logo.png" width="200" height="100" class="img-grey mautomargin"></a></li>
 
     <li><img src="https://static.igem.org/mediawiki/2015/8/8b/NRP-UEA-Norwich-TSL-logo.png" width="200" height="100" class="img-grey mautomargin"></a></li>
 
     <li><img src="https://static.igem.org/mediawiki/2015/8/8b/NRP-UEA-Norwich-TSL-logo.png" width="200" height="100" class="img-grey mautomargin"></a></li>
     <li><img src="https://static.igem.org/mediawiki/2015/f/f0/NRP-UEA-Norwich-Biochemsociety.png" width="225" height="100" class="img-grey mautomargin"></a></li>
+
     <li><img src="https://static.igem.org/mediawiki/2015/7/7d/NRP-UEA-Norwich-SEB-Logo.png" width="225" height="100" class="img-grey mautomargin"></a></li>
 
     <li><img src="https://static.igem.org/mediawiki/2015/d/d3/NRP-UEA-Norwich-JIC.png" width="200" height="100" class="img-grey mautomargin" width="200" height="100"></a></li>
 
     <li><img src="https://static.igem.org/mediawiki/2015/d/d3/NRP-UEA-Norwich-JIC.png" width="200" height="100" class="img-grey mautomargin" width="200" height="100"></a></li>
 
     <li><img src="https://static.igem.org/mediawiki/2015/c/c5/NRP-UEA-Norwich-Bbsrc.png" width="200" height="100" class="img-grey mautomargin"></a></li>
 
     <li><img src="https://static.igem.org/mediawiki/2015/c/c5/NRP-UEA-Norwich-Bbsrc.png" width="200" height="100" class="img-grey mautomargin"></a></li>
Line 256: Line 215:
 
     <li><img src="https://static.igem.org/mediawiki/2015/e/e3/NRP-UEA-Norwich-Wellcome_Trust_logo.png" width="250" height="100" class="img-grey mautomargin"></a></li>
 
     <li><img src="https://static.igem.org/mediawiki/2015/e/e3/NRP-UEA-Norwich-Wellcome_Trust_logo.png" width="250" height="100" class="img-grey mautomargin"></a></li>
 
     <li><img src="https://static.igem.org/mediawiki/2015/7/74/NRP-UEA-Norwich-IBBA_logo.png" width="125" height="125" class="img-grey mautomargin"></a></li>
 
     <li><img src="https://static.igem.org/mediawiki/2015/7/74/NRP-UEA-Norwich-IBBA_logo.png" width="125" height="125" class="img-grey mautomargin"></a></li>
 +
    <li><img src="https://static.igem.org/mediawiki/2015/d/d0/NRP-UEA-Norwich-SfAM-Logo.png" width="220" height="100" class="img-grey mautomargin" width="200" height="100"></a></li>
  
  

Latest revision as of 10:42, 21 October 2015

House of Carbs

Manchester-Graz Collaboration

The Manchester-Graz team have developed an expression system designed to regulate single and multi-gene pathways for an intestine expression. For controlling a wide range of pathways it is designed in a flexible and modular manner. They tested the production of butyrate in the gut. The pathway was incorporated into the expression system model to observe the expression of butyrate under the control of the developed system. The model generated helped us to understand how the system is dealing with pathways that consist of several enzymes at an intestinal level.

The system consists of two quorum sensing (QS) systems EsaR/I and CepR/I. The EsaR/I system belongs to the plant pathogen Pantoea stewartii . The second QS-System, CepR/I, belongs to the opportunistic pathogen Burkholderia cenocepacia . For details about the system and the model please look into the Manchester-Graz modelling page.

...

Figure 1: Overview of the reduced pathway. Coenzyme A (CoA) is recycled in the pathway by the butyryl CoA-acetyl CoA-tranferase.

Butyrate is converted starting from two acetyl-CoAs over several steps to butyryl-CoA. In the last step, the coenzyme A is transferred to acetate, producing acetyl-CoA and butyrate1. For simplicity, the pathway was reduced to some essential parts and steps in the pathway. Acetate is converted to acetyl-CoA. The steps to butyryl-CoA are reduced to one step. Coenzyme A is recycled in the last step to butyrate and can be reused to produce acetyl-CoA (Figure 1).

The pathway is controlled by three enzymes whose expression is controlled by the two quorum sensing systems.

If we simulate the model, in the first two minutes the acetate gets first converted into butyryl-CoA and then the butyrate production starts (see Figure 2). The following time is butyrate being produced constantly by the cells. The butyrate is transported out of the cells through diffusion by a rate of 207.6 µmol/h/L or 18 mg/h/L.

...

Figure 2: Butyrate production in the first two minutes.

...

Figure 3: Overview of the Simbiology model. For simplification the model was reduced to essential components.

References

1. Susan E et al (2002) The microbiology of butyrate formation in the human colon.

MANY THANKS TO OUR SPONSORS

Useful Links

Contact Us

  • nrpuea.igem2015@gmail.com

  • Norwich Research Park,
  • Colney,
  • Norwich, NR4 7UH, UK.

We are the NRP-UEA-Norwich 2015 iGEM Team.

Designed and developed by the NRP-UEA-Norwich iGEM Team